MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Biotel Inc. announced strong sales and earnings for its second quarter ended December 31, 2007. The Company had net earnings of $206,000, or $0.07 per diluted share, on revenues of $2,859,000. This compares to net earnings of $120,000, or $0.04 per diluted share, on revenues of $2,705,000 for the second quarter of last year. For the six months ended December 31, 2007, Biotel had net earnings of $376,000, or $0.13 per diluted share, on revenues of $5,610,000. This compares to net earnings of $109,000, or $0.04 per share, on revenues of $5,129,000 for the firsts six months last year.
“We are pleased with our business progress in the second quarter, achieving strong improvement in margins as well as year over year growth in product and service revenues,” Biotel President and CEO Steve Springrose said. “Underlying these results were strong sales of our Braemar cardiac event recorders, Holter devices, liposuction and other medical devices. On top of this, revenues from our Agility 24/7 cardiac monitoring services continued to grow, and the service component of our business contributed significantly to gross margin improvement. Year-over year growth in R&D continued to support our new product pipeline, including the ER900 Wireless Event Recorder, as well as other new cardiac event and Holter recorders. In keeping with our long-term strategy, Biotel continues to serve as a development partner to medical corporations seeking new devices and clinical research services.”
CONTACT: Judy Naus of Biotel Inc., +1-651-286-8623, info@biotelinc.com
Web site: http://www.biotelinc.com/
